Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | REN | P00797 | 2/20 | 0.34 |
| ▸ | METAP1 | P53582 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 3/20 | 0.33 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13242434 | 0.98 | CYP1A2 (0.41) | CYP1A2METAP2DPP4ALDH1A1KMT2A | |
| SCHEMBL9076360 | 0.98 | CYP1A2 (0.41) | CYP1A2METAP2DPP4ALDH1A1KMT2A | |
| Hydrochloric Acid SCHEMBL11372546 | 0.96 | CYP1A2 (0.40) | CYP1A2METAP2DPP4ALDH1A1KMT2A | |
| SCHEMBL20962096 | 0.95 | ANPEP (0.36) | CYP1A2METAP2DPP4ALDH1A1KMT2A | |
| SCHEMBL16982707 | 0.95 | ANPEP (0.36) | CYP1A2METAP2DPP4ALDH1A1KMT2A | |
| SCHEMBL2633053 | 0.91 | — | — | |
| SCHEMBL26741692 | 0.91 | — | — | |
| SCHEMBL5072427 | 0.85 | CYP1A2 (0.48) | CYP1A2METAP2DPP4ALDH1A1KMT2A | |
| SCHEMBL8229893 | 0.85 | CYP1A2 (0.48) | CYP1A2METAP2DPP4ALDH1A1KMT2A | |
| SCHEMBL24684546 | 0.84 | ALDH1A1 (0.47) | CYP1A2METAP2ALDH1A1KMT2AREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008148754-A2 | MACROCYCLES AND THEIR USES | NOVARTIS AG (CH) | 2008-12-11 | — | — | WO | disclosed |